Skip to content

Public FDA record

Z-2264-2024: DxI 9000 Access Immunoassay Analyzer, C11137; in-vitro diagnostic

Recall record Z-2264-2024 for Beckman Coulter, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2264-2024
Company in FDA record
Beckman Coulter, Inc.
FDA classification date
Jul 3, 2024
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Beckman Coulter is recalling their DxI 9000 Access Immunoassay Analyzers, an in vitro diagnostic device used for the quantitative, semi-quantitative, or qualitative determination of various analyte concentrations found in human body fluids, by correction. The reason for the recall is: Beckman Coulter has determined that the DxI 9000 Access Immunoassay analyzer accepts calibrator values scanned from multiple calibrator cards when an operator configures a new calibrator lot. The analyzer accepts the calibrator lot values from any scanned calibrator card, regardless of the assay test code or calibrator material lot number. The software is not validating the integrity of each calibrator barcode scanned to ensure they are all from the same calibrator card. This includes all software versions and all DxI 9000 instruments that are currently in the field. This issue does not impact calibrator material with 2D calibrator card barcodes. This may cause a failed calibration curve. The health risk to patients is dependent upon the analytes that could be impacted by the error, to include receiving delayed or erroneous results. The issue was identified by Beckman Coulter while conducting a field action on DxI 9000 Access Immunoassay Analyzers.

Source facts

Action
Beckman Coulter issued an URGENT MEDICAL DEVICE RECALL notice to its consignees on 04/18/2024 via USPS first class mail. The notice explained the issue, impact, and requested the following actions be taken: "x Confirm that the DxI 9000 Access Immunoassay Analyzer test name printed on the calibrator card matches the calibrator material name before you configure the calibrator lot. x Scan each individual calibrator card and complete each step displayed on the DxI 9000 Access Immunoassay Analyzer user interface before you scan the next calibrator card. x Review the expected values column on the calibration summary details page and confirm that values for that assay match the values printed on the calibration card. If a calibrator lot had incorrect calibrator levels configured take the following steps: x Delete the impacted calibrator lot: Select Menu > Calibration Material List, select the desired calibration lot, and select Delete. x Reconfigure the correct calibrator lot as described in the Calibration section of the Instructions for Use (IFU). x Rerun the calibration." "Your Beckman Coulter service representative will contact you to schedule the software upgrade when it is available. Please share this information with your laboratory staff and retain this notification as part of your laboratory Quality System documentation. If you have forwarded any of the affected product(s) listed above to another laboratory, please provide them a copy of this letter."
Initiated
2024-04-18
Root cause
Software design
Distribution
Worldwide distribution.
Recall number
Z-2264-2024
Recall status
Open, Classified
CDRH record ID
207321
FDA classified
2024-07-03
Recall event number
94499

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗